InMed Pharmaceuticals Inc.INMNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank79
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-0.39
↑ 91% vs avg
Percentile
P79
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
-4.19
Historical baseline
PeriodValueYoY Change
2025-0.39-55.6%
2024-0.25+12.6%
2023-0.29-1916.4%
2022-0.01+99.2%
2021-1.69+65.5%
2020-4.89+14.7%
2019-5.74+64.3%
2018-16.05-71.9%
2017-9.34-182.7%
2016-3.30-